Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer

Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer / Martini, A., Jia, R., Ferket, B.s., Waingankar, N., Plimack, E.r., Crabb, S.j., Harshman, L.c., Yu, E.y., Powles, T., Rosenberg, J.e., Pal, S.k., Vaishampayan, U.n., Necchi, A., Wiklund, N.p., Mehrazin, R., Mazumdar, M., Sfakianos, J.p., Galsky, M.d.. - In: CANCER. - ISSN 0008-543X. - 125:18(2019), pp. 3155-3163. [10.1002/cncr.32169]